GlassScriptPhysician profile
Po N Lam
NPI 1043265747
$81,489.02
in general payments reported to CMS, 2019-2025
49 companies · $51K in 2025
The $51K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,309 · 2020: $354 · 2021: $559 · 2022: $4,801 · 2023: $15K · 2024: $8,440 · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Consulting Fee: $17K · Education: $16K · Food and Beverage: $13K · Travel and Lodging: $8,195 · Honoraria: $3,825 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,000.00 |
| Consulting Fee | $16,912.06 |
| Education | $16,000.00 |
| Food and Beverage | $12,510.87 |
| Travel and Lodging | $8,195.39 |
| Honoraria | $3,825.00 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $26,866.89 | 2022-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Avyxa Pharma, LLC | $18,736.62 | 2025 | |
| Ferring Pharmaceuticals INC. | $6,503.87 | 2023-2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $6,109.68 | 2023-2025 | Imfinzi, Lynparza |
| Urogen Pharma, INC. | $4,240.89 | 2022-2025 | Jelmyto |
| Janssen Biotech, INC. | $4,071.09 | 2019-2025 | Erleada, Akeega, Rybrevant |
| Astellas Pharma US INC | $3,165.20 | 2022-2025 | Padcev, Xtandi |
| Angiodynamics, INC. | $1,608.18 | 2025 | Nanoknife |
| Bioprotect Medical, INC. | $1,568.31 | 2025 | Bioprotect Balloon Implant System |
| Merck Sharp & Dohme LLC | $1,234.70 | 2019-2024 | Keytruda, Lynparza |
| Telix Pharmaceuticals | $1,044.43 | 2024-2025 | Illuccix |
| Conmed Corporation | $573.56 | 2023 | Airseal |
| Bayer Healthcare Pharmaceuticals INC. | $539.12 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $525.40 | 2024-2025 | |
| Immunitybio, INC. | $518.75 | 2024-2025 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $479.37 | 2019-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $366.43 | 2021-2025 | Prolaris |
| Teleflex LLC | $361.83 | 2023-2024 | Urolift |
| Coloplast Corp | $317.49 | 2023-2024 | Coloplast Tfl Drive |
| Baxter Healthcare | $259.79 | 2025 | Perclot |
| Calyxo, INC. | $232.62 | 2025 | Cvac Aspiration System |
| Palette Life Sciences, INC. | $225.97 | 2022 | |
| Sumitomo Pharma America, INC. | $187.63 | 2023-2025 | Orgovyx |
| Neotract INC. | $161.49 | 2019-2020 | |
| Olympus America INC. | $156.61 | 2020-2025 | Itind System |
| Tolmar, INC. | $151.45 | 2024 | |
| Davol INC. | $146.01 | 2023 | Phasix Mesh |
| Progenics Pharmaceuticals, INC. | $145.39 | 2023-2024 | Pylarify |
| Histosonics, INC. | $142.42 | 2025 | |
| Procept Biorobotics Corporation | $135.75 | 2025 | |
| Accord Healthcare, INC. | $107.03 | 2024-2025 | |
| Eisai INC. | $100.31 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $98.06 | 2019 | |
| Abbvie INC. | $79.25 | 2019-2025 | |
| Cardinal Health 108 LLC | $45.18 | 2024 | |
| Ethicon US, LLC | $39.94 | 2020 | |
| Janssen Scientific Affairs, LLC | $30.52 | 2024 | Erleada |
| Alnylam Pharmaceuticals INC. | $25.65 | 2025 | Givlaari |
| Agiliti Surgical, INC. | $22.50 | 2023 | Sonablate |
| E.R. Squibb & Sons, L.L.C. | $18.96 | 2025 | Opdivo |
| Amgen INC. | $18.89 | 2021 | |
| Antares Pharma, INC. | $18.04 | 2020 | |
| Endo USA, INC. | $17.52 | 2025 | Aveed, Xiaflex |
| Myovant Sciences INC. | $17.35 | 2021 | |
| Bayer Healthcare LLC | $17.27 | 2025 | |
| Boston Scientific Corporation | $16.02 | 2025 | Axonics |
| Otsuka America Pharmaceutical, INC. | $13.78 | 2022 | |
| 180 Medical, INC. | $13.37 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $12.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Po Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.